Catalan delegation returns to BIO International Convention with 28 companies and organizations from the BioRegion

The upcoming edition of BIO International Convention, the top partnering fair in the biotechnology and biopharma sectors, will be held from 19 to 22 June 2017 at the San Diego Convention Center (United States). The Catalan delegation to this year’s event, coordinated by Biocat, will feature 28 companies and organizations from the BioRegion, mainly from the biotechnology and pharmaceutical arena, as well as research, consultancy and service organizations.

In the Spanish pavilion coordinated by ICEX (booth #5315) and located next to the main sponsors and meeting areas, the BioRegion of Catalonia will have its own booth with more than 30 square meters of space. In this area, five Catalan companies will also have their own booths, for greater visibility: BCN Peptides, Oryzon Genomics, Salvat Biotech, Trifermed and Zeclinics. In the general exhibition area of the fair, Grífols will also have its own independent booth (#5007).

The Catalan delegation this year will include companies that have now participated in more than five editions, like Bioibérica and GP Pharm, as well as others doing so for the first time ever, like Nostrum Discovery and Pharmacelera. Other participants include Ability Pharma,  Almirall, Alta Life Sciences, Archivel Farma, Biokit, Catalonia Trade & Investment (through their New York office), Center for Genomic Regulation (CRG), Readycell, VHIR, Germans Tries i Pujol Research Institute (IGTP), Barcelona Science Park (PCB), Intelligent Pharma, Iproteos, Uriach, Esteve, Spherium Biomed and Grupo Ferrer Internacional.

Partnering opportunities in one of the most innovative ecosystems in the world

BIO International Convention expects to attract nearly 16,000 industry leaders and 2,500 top executives from more than 4,000 international companies and institutions. They also expect to have more than 1,400 exhibitors from around the world and host nearly 35,000 partnering meetings, all of which means great business opportunities for participants. One of BIO’s main points of value added is access to the one-on-one partnering system and the opportunity to set up meetings and juggle agendas with the top companies and institutions before and during the fair.

The state of California is home to one of the most cutting-edge life sciences ecosystems in the fields of innovation and productivity and is based in the San Diego and San Francisco areas. There are more than 3,400 companies working in industrial biotechnology, biofuel and biopharmaceuticals, and medical and diagnostic technology, among others.

BIO International Convention offers the largest exhibition area in the world for companies in the sector and an extensive program of activities ranging from networking to business pitches, supersessions and seminars on new trends in the biotechnology arena, as well as innovations in science and technology. This year, the fair will feature speakers like David Cameron, former prime minister of the United Kingdom, and Kathleen Rubins, the first astronaut to sequence DNA in space.